<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:30:27" record="15281" source="Espacenet">
	<entities>
		<entity ref="Patent15281" type="Patent">
			<semanticIdentifier>brcris::623254cabb0a8006ab9a7c2e6a241524</semanticIdentifier>
			<semanticIdentifier>docdb::BR102013019138A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102013019138</semanticIdentifier>
			<semanticIdentifier>docdb::BR102013019138A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20131019138</semanticIdentifier>
			<semanticIdentifier>original::102013019138</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102013019138"/>
			<field name="identifier.lattes" value="1504496062851809"/>
			<field name="identifier.espacenet" value="102013019138"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="composição vacinal contra toxoplasmose e linfadenite caseosa utilizando corynebacterium pseudotuberculosis recombinante"/>
			<field name="title.lattes" value="COMPOSIÇÃO VACINAL CONTRA TOXOPLASMOSE E LINFADENITE CASEOSA UTILIZANDO Corynebacterium pseudotuberculosis RECOMBINANTE"/>
			<field name="depositDate" value="2013-07-26"/>
			<field name="publicationDate" value="2016-09-20"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="FERNANDA ALVES DORELLA"/>
			<field name="inventor" value="MARA CAMILA ARANTES MARQUES DE AGUIAR"/>
			<field name="inventor" value="OSCAR BRUNA ROMERO"/>
			<field name="inventor" value="VASCO ARISTON DE CARVALHO AZEVEDO"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DE MINAS GERAIS"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K39/012AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="39"/>
				<field name="subgroup" value="012AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61P31/04AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="04AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P33/02AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="33"/>
				<field name="subgroup" value="02AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="C07K14/45AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="K"/>
				<field name="group" value="14"/>
				<field name="subgroup" value="45AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="C12N1/21AI"/>
				<field name="section" value="C"/>
				<field name="class" value="12"/>
				<field name="subclass" value="N"/>
				<field name="group" value="1"/>
				<field name="subgroup" value="21AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="6"/>
				<field name="text" value="C12N15/30AI"/>
				<field name="section" value="C"/>
				<field name="class" value="12"/>
				<field name="subclass" value="N"/>
				<field name="group" value="15"/>
				<field name="subgroup" value="30AI"/>
			</field>
			<field name="abstract.espacenet" value="composiqao vacinal contra toxoplasmose e linfadenite caseosa utilizando corynebacterium pseudotuberculosis recombinante a presente invengao consiste em uma composigéo vacinal recombinante com atividade profilatica para infecgoes por toxoplasma gondii e corynebacterium pseudotuberculosis, concomitantemente, em animais, preferencialmente, caprinos e ovinos. fundamenta-se no emprego de c. pseudotuberculosis atenuadas recombinantes, capazes de expressar proteinas imunogénicas para resposta antitoxoplasma codificadas pelas sequéncias modificadas sag1 (seq id n° 1), sag2 (seq id n° 2) e sag3 (seq id n° 3). esta invengao apresenta a vantagem de diminuir a perda produtiva nos rebanhos, bem como reduzir 0 risco de transmissao da toxoplasmose a consumidores humanos. séo inegaveis também as vantagens econémicas de vacinas capazes de imunizar contra mais de_ uma doenga sobre vacinas monovalentes, tanto no contexto de produgao industrial como no contexto de um protocolo clnico de imunizagao. a tecnologia também se refere a bactéria recombinante produzida, que foi capaz de expressar as proteinas do t. gondii corretamente e de estimular uma resposta humoral nos camundongos imunizados com este vetor, bem como 0 uso da composigao e da bactéria nessa atividade profilatica, bem como os plasmideos construidos e incorporados a essa bactéria."/>
			<field name="originatesFrom" value="56958542"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102013019138"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102013019138"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102013019138"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20131019138"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102013019138"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person10607" type="Person">
			<semanticIdentifier>lattes::1504496062851809</semanticIdentifier>
			<field name="identifier.lattes" value="1504496062851809"/>
			<field name="name" value="Fernanda Alves Dorella"/>
		</entity>
		<entity ref="OrgUnit8281" type="OrgUnit">
			<semanticIdentifier>brcris::b325025cd443a1ebf025d67185ebad24</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE FEDERAL DE MINAS GERAIS"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent15281" toEntityRef="Person10607" type="Inventor"/>
		<relation fromEntityRef="Patent15281" toEntityRef="OrgUnit8281" type="Applicant"/>
	</relations>
</entity-relation-data>
